Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - Other
Ratios

ARS Pharmaceuticals (SPRY) Receivables - Net (2024 - 2025)

ARS Pharmaceuticals' Receivables - Net history spans 2 years, with the latest figure at $25.3 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 210.06% year-over-year to $25.3 million; the TTM value through Dec 2025 reached $25.3 million, up 210.06%, while the annual FY2025 figure was $25.3 million, 210.06% up from the prior year.
  • Receivables - Net for Q4 2025 was $25.3 million at ARS Pharmaceuticals, down from $36.5 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $36.5 million in Q3 2025 and bottomed at $773000.0 in Q3 2024.